AI assistant
Surgery Partners, Inc. — Director's Dealing 2022
Mar 2, 2022
31430_dirs_2022-03-02_21857544-a59f-4b22-babb-eb9d25a447e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Surgery Partners, Inc. (SGRY)
CIK: 0001638833
Period of Report: 2022-02-10
Reporting Person: Goodwin George (President, ASC Group)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-28 | Common Stock | S | 3777 | $52.23 | Disposed | 96038 | Direct |
| 2022-02-10 | Common Stock | A | 5233 | $42.04 | Acquired | 101271 | Direct |
Footnotes
F1: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 24, 2022.
F2: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: Shares issued based on 2021 performance under performance stock unit awards granted to the Reporting Person on March 10, 2021. Shares will vest in two equal annual installments on each of the first two anniversaries of February 10, 2022.